CHRONOSCALE CORPORATION (CHRN)
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-09-04
$20.26+0.90%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · CHRN
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 346.6% |
| Our one-year growth estimate | diamond | -23.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 369.6 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name has been missing across recent quarters and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 38 industry peers
CHRN — divestiture
Dated 2026-06-30
Other Events. In connection with the Business Combination, the Company is providing the following supplemental disclosure solely for informational purposes: ● Exhibit 99.1 filed with this Amendment No. 2 includes the disclosure required by Part II, Item 7 (Management’s Discussion and Analysis of Financial Condition and Results of Operations) of Form 10-K, provided with respect to Cloud as of and for the fiscal years ended May 31, 2025 and May 31, 2024 and as of and for the subsequent interim…
Why it matters: Finishing the sale of Ekso Bionics shows focus on the cloud business. This could improve financial stability.
Supportive ifAn official announcement will confirm that the sale of Ekso Bionics is done.
Worry ifNo news or delays in the sale process beyond the planned timeline.
Why it matters: Better margins signal progress in managing costs. This is crucial for turning around losses.
Supportive ifGross profit increases to over $1.5M in the next quarter.
Worry ifGross profit drops below $1.0M in the next quarter.
Why it matters: Getting new money shows management can pay for operations and growth.
Supportive ifA new capital raise over $50 million will be announced through debt or equity.
Worry ifNo new capital raises announced in the next quarter.
Why it matters: This deployment is a key growth initiative for ChronoScale. It shows their ability to scale AI infrastructure.
Supportive ifA press release says the 50 MW AI compute system was set up successfully.
Worry ifThere were no updates or delays for the deployment schedule.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$452 on $10,000 · ±4.5% | How much price usually moves either way. |
| Bad day | $953 loss on $10,000 · 9.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,040 loss on $10,000 · 40.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Selling Ekso Bionics helps ChronoScale focus on its cloud business. This may help finances.
Supportive ifThey announced the successful sale of Ekso Bionics.
Worry ifDelays or failure to complete the divestiture as planned.
Why it matters: Losing more money may show problems with managing costs and growing the business.
Worry ifOperating losses are more than -$5.6M in the next quarterly report.
Less concerning ifOperating losses improve or stay below -$5.6M.
Why it matters: Getting more money is important for growth and operations. Success or failure affects finances.
Watch forThey announced raising more money beyond the $100 million line of credit.
Also watch forNot getting more money or delays in financing plans.